コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 y virus, equine infectious anemia virus, and feline immunodeficiency virus.
2 been obtained from animals infected with the feline immunodeficiency virus.
3 us, human immunodeficiency virus type 1, and feline immunodeficiency virus.
4 his model can also explain 3TC resistance in feline immunodeficiency virus and human hepatitis B viru
6 ly inhibit replication of human, simian, and feline immunodeficiency viruses and therefore has broad-
7 tiviruses equine infectious anemia virus and feline immunodeficiency virus, and has no effect on the
8 the dominant selective force acting on this feline immunodeficiency virus as it replicates in a new
10 d into the articular joint space a defective feline immunodeficiency virus capable of infecting divid
11 ne was prepared from a pathogenic isolate of feline immunodeficiency virus containing a mutation that
12 s, we evaluated the molecular evolution of a feline immunodeficiency virus derived from a wild cougar
13 ion, delivery of this shRNA by a recombinant feline immunodeficiency virus effectively silenced torsi
14 tant role that CXCR4 plays in infection with feline immunodeficiency virus, expression on PBMC in viv
15 ction with the prototypic Petaluma strain of feline immunodeficiency virus (FIV(PET)) using vaccines
16 GFAP-IL-1betaXAT mice were injected with the feline immunodeficiency virus (FIV) (Cre) vector in the
19 on the two pathogenic retroviruses in cats, feline immunodeficiency virus (FIV) and feline leukemia
21 To determine its antiviral activity against feline immunodeficiency virus (FIV) and HIV, the activit
23 ThX and mock-ThX cats were inoculated with feline immunodeficiency virus (FIV) and monitored for th
26 semen from male domestic cats infected with feline immunodeficiency virus (FIV) can transmit virus t
32 6-residue multiepitopic synthetic peptide of feline immunodeficiency virus (FIV) comprising immunodom
33 tested the hypothesis that vectors based on feline immunodeficiency virus (FIV) could be used for co
35 to provide insights into how hunting shapes feline immunodeficiency virus (FIV) dynamics in puma (Pu
36 combinant soluble CD134 (sCD134) facilitated feline immunodeficiency virus (FIV) entry into CXCR4-pos
38 (n = 19) had been chronically infected with feline immunodeficiency virus (FIV) for over 6 years, wh
41 an immunodeficiency virus type 1 (HIV-1) and feline immunodeficiency virus (FIV) had different patter
43 Similar to human immunodeficiency virus, feline immunodeficiency virus (FIV) induces immunodefici
46 s during the acute stage (first 4 months) of feline immunodeficiency virus (FIV) infection in laborat
48 A monoclonal antibody, MAb vpg15, inhibits feline immunodeficiency virus (FIV) infection in tissue
52 vestigating the effect of CCR5 expression on feline immunodeficiency virus (FIV) infection must be in
53 cells (Tregs) activated during the course of feline immunodeficiency virus (FIV) infection suppress C
55 rly target cells and tissues in transmucosal feline immunodeficiency virus (FIV) infection, cats were
66 evelopment of gene delivery vectors based on feline immunodeficiency virus (FIV) is an attractive alt
68 ogenetic distance from primate lentiviruses, feline immunodeficiency virus (FIV) is becoming the lent
69 of equine infectious anemia virus (EIAV) and feline immunodeficiency virus (FIV) is inhibited by lept
73 ptional elements within the U3 domain of the feline immunodeficiency virus (FIV) long terminal repeat
79 candidates were tested for activity against feline immunodeficiency virus (FIV) on infected CrFK cel
81 were evaluated for their incorporation onto feline immunodeficiency virus (FIV) particles, transduct
84 A novel fluorogenic substrate for continuous feline immunodeficiency virus (FIV) protease (PR) assay
87 an immunodeficiency virus type 1 (HIV-1) and feline immunodeficiency virus (FIV) proteases (PRs).
90 ilar to human immunodeficiency virus type 1, feline immunodeficiency virus (FIV) replicates in the th
91 ron (IFN-alpha) induced tetherin and blocked feline immunodeficiency virus (FIV) replication in lymph
92 regulatory properties and ability to support feline immunodeficiency virus (FIV) replication in vitro
95 ily conserved on both HIV type 1 (HIV-1) and feline immunodeficiency virus (FIV) reverse transcriptas
102 t syncytium formation mediated by strains of feline immunodeficiency virus (FIV) that have been selec
103 immunodeficiency virus (HIV) and strains of feline immunodeficiency virus (FIV) that have been selec
107 ssion in arthritic joints of mice, using the feline immunodeficiency virus (FIV) vector, which is cap
109 V), bovine immunodeficiency virus (BIV), and feline immunodeficiency virus (FIV) Vif appear specific
112 y RNA ligands for reverse transcriptase from feline immunodeficiency virus (FIV) were isolated from a
113 an immunodeficiency virus type 1 (HIV-1) and feline immunodeficiency virus (FIV) were prepared to exa
114 binant Vif derived from the 34TF10 strain of feline immunodeficiency virus (FIV) were used to assess
115 we generated a defective mutant provirus of feline immunodeficiency virus (FIV) with an in-frame del
117 ore than 20 feline species test positive for feline immunodeficiency virus (FIV), a lineage of lentiv
118 d from the pathogenic GL8 molecular clone of feline immunodeficiency virus (FIV), a range of viral va
119 xamined the brains of cats infected with the feline immunodeficiency virus (FIV), an animal model of
120 human immunodeficiency virus type 1 (HIV-1), feline immunodeficiency virus (FIV), and equine infectio
121 l leukemia virus type 1 (HTLV-1), HIV-1, and feline immunodeficiency virus (FIV), and have been postu
122 Human immunodeficiency virus type 1 (HIV-1), feline immunodeficiency virus (FIV), and Moloney murine
123 BIV), equine infectious anemia virus (EIAV), feline immunodeficiency virus (FIV), and Rous sarcoma vi
124 cells and cell lines did not restrict HIV-1, feline immunodeficiency virus (FIV), equine infectious a
126 tes for three species groups of lentiviruses-feline immunodeficiency virus (FIV), simian immunodefici
127 of CD134 is the primary binding receptor for feline immunodeficiency virus (FIV), targeting the virus
128 (fCD134) is the primary binding receptor for feline immunodeficiency virus (FIV), targeting the virus
129 f human acquired immune deficiency syndrome, feline immunodeficiency virus (FIV), was used to model m
132 r efficiency and tissue or cell tropism of a feline immunodeficiency virus (FIV)-based lentiviral vec
134 natural lung tropism; however, pseudotyping feline immunodeficiency virus (FIV)-based lentiviral vec
135 pression following a single application of a feline immunodeficiency virus (FIV)-based lentivirus vec
136 epatoma cells following gene transfer with a feline immunodeficiency virus (FIV)-based lentivirus vec
137 arget these apical receptors, we pseudotyped feline immunodeficiency virus (FIV)-based vectors by usi
140 gical signals' alterations, we have used the feline immunodeficiency virus (FIV)-derived gp120 and ev
141 influence of the protease inhibitor TL-3 on feline immunodeficiency virus (FIV)-induced central nerv
142 We analyzed antibody responses in sera from feline immunodeficiency virus (FIV)-infected and uninfec
143 and immunodeficiency is a characteristic of feline immunodeficiency virus (FIV)-infected cats, it is
144 s were mucosally challenged with 10(2)-10(6) feline immunodeficiency virus (FIV)-infected T cells.
157 immunity to infection can be induced against feline immunodeficiency virus (FIV); however, protection
158 ase (IN) mutants for a non-human lentivirus (feline immunodeficiency virus [FIV]) and analyzed both t
160 onprimate lentiviral genomic RNAs (HIV-1 and feline immunodeficiency virus [FIV]) vis-a-vis their Gag
161 , we demonstrate that a fast-evolving virus (feline immunodeficiency virus, FIV) can reveal details o
162 transmission pathways for three subtypes of feline immunodeficiency virus (FIVPle ) in African lions
164 tranasal insulin treatment of experimentally feline immunodeficiency virus-infected animals resulted
167 s of MLV integrase and truncated variants of feline immunodeficiency virus integrase, suggesting that
169 ian immunodeficiency virus, puma lentivirus, feline immunodeficiency virus, Jembrana disease virus, v
170 The earliest experiments were in the cat/feline immunodeficiency virus model, followed a decade l
173 d with feline lentiviruses (puma lentivirus, feline immunodeficiency virus Pco [FIV-Pco], referred to
174 structures of complexes of a D30N mutant of feline immunodeficiency virus protease (FIV PR) complexe
176 es in success when targeting HIV-1 protease, feline immunodeficiency virus protease, and HIV-1 integr
177 S3' subsite binding specificities of HIV and feline immunodeficiency virus proteases (FIV) proteases
178 l cross-species transmission of a subtype of feline immunodeficiency virus, puma lentivirus A (PLVA),
181 of cells productively infected with HIV-1 or feline immunodeficiency virus revealed dramatic patterns
182 nus of tRNA(Lys,3) and the U5-IR loop of the feline immunodeficiency virus RNA genome suggests a nove
184 of HIV, infection of neonatal cats with the feline immunodeficiency virus, showed development of per
185 enetic diversity, and molecular evolution of feline immunodeficiency virus specific to cougars (FIVpc
186 used to compare the nucleotide sequences of feline immunodeficiency virus strains isolated from Texa
187 eported previously for functional binding of feline immunodeficiency virus SU to its coreceptor CD134
188 zed a highly pathogenic molecular isolate of feline immunodeficiency virus subtype C (FIV-C) CABCpady
189 of cellular receptors for human, simian, and feline immunodeficiency viruses that are tropic for lymp
192 , we report that human DC-SIGN also captures feline immunodeficiency virus via high-affinity (1 nM),